Hima Atluri, MD

Wonderful podcast featuring two former co-fellows about the critical relationships between community and academic oncology! So proud of @benfangman and @kyleconcannon4 - thanks for highlighting this important topic!

EP6 is live on YouTube and major platforms! Community oncologist @benfangman, physician-scientist @kyleconcannon4, and patient @SamanthaM75074 discuss local vs academic care. Ep 06: Academic Vs. Community Oncology | Cracking Cancer Podcast youtu.be/1d0F2AMjhhY?si… via @YouTube

👉👉👉Delighted to share our brand new original report 🚨 led by our Dr @HannahGoulart & @doctorpemm ➡️oral DAC+VEN for #BPDCN || @MDAndersonNews #endcancer tandfonline.com/doi/full/10.10…

@RyanDenu @MDAndersonNews @JenMarvinPeek @MichaelLaPelusa @HannahGoulart @Laura_B_Amin @tonygazibo @doctorpemm @NitinJainMD @sanamloghavi @TapKadia @Daver_Leukemia

And just like that, I’m already a lame duck chief. Congrats to our new @MDAndersonNews heme/onc fellowship chiefs for 2025-2026: @JenMarvinPeek @MichaelLaPelusa @HannahGoulart Sushanth Gouni @Laura_B_Amin @tonygazibo

@GIMedOnc @RyanDenu @MDAndersonNews @JenMarvinPeek @MichaelLaPelusa @HannahGoulart @Laura_B_Amin @tonygazibo Congrats to @HannahGoulart for taking heme chief for 18 months! Not an easy feat - but can think of no one better to do it!

@RyanDenu @MDAndersonNews @JenMarvinPeek @MichaelLaPelusa @HannahGoulart @Laura_B_Amin @tonygazibo Way to hold the ship together! I wonder who has the sacred privilege of heme chief…

AFC CHAMPS THREE YEARS RUNNING 🏆

Adding venetoclax to intensive chemotherapy with cladribine, idarubicin, and cytarabine resulted in deep and durable remissions in young, fit patients with newly diagnosed #AML or #MDS, according to a study presented by @TapKadia of @MDAndersonNews. 📰 buff.ly/42ozFT8

Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia aacrjournals.org/bloodcancerdis… #AMLsm

👉👉Last clinic day for Hima @HimaglobinA with us. Will miss her. Wonderful clinician, researcher and colleague. All the very best in your new adventure at @NorthwesternMed 🙏🏽🙏🏽👏👏 cc @doctorpemm @TapKadia @jaltmanmd

Grateful for good friends and great mentors #womeninmedicine

@jenweiying @doctorpemm @LaGriglia_TX @garciamanero @TapKadia @DrHKantarjian @BraishJulie @AkhilJainMD @SamUrrutia_ @PatriceNasnas @AlmanzaLeukMD @jayastuMD @NitinJainMD @Daver_Leukemia @GBorthakur @mkonople @TalhaBadarMD @FadiHaddad_MD @mtmdphd @GMontalbanBravo @HannahGoulart @MDAndersonNews Where am I?!

@doctorpemm @LaGriglia_TX @garciamanero @TapKadia @DrHKantarjian @HimaglobinA @BraishJulie @AkhilJainMD @SamUrrutia_ @PatriceNasnas @AlmanzaLeukMD @jayastuMD @NitinJainMD @Daver_Leukemia @GBorthakur @mkonople @TalhaBadarMD @FadiHaddad_MD @mtmdphd @GMontalbanBravo @HannahGoulart I love this place and our department so much!!! We are truly a family. Now… presenting the ladies of @MDAndersonNews leukemia!!! ❤️❤️❤️

👉👉👉Super fun evening celebrating our beloved Leukemia Fellows at our annual Leukemia Fellowship Graduation at @LaGriglia_TX ! 🙌 @garciamanero @TapKadia @DrHKantarjian || @HimaglobinA @BraishJulie @AkhilJainMD @SamUrrutia_ @PatriceNasnas @jenweiying @doctorpemm @AlmanzaLeukMD

@NitinJainMD @NorthwesternMed @doctorpemm @TapKadia @jaltmanmd So grateful for your incredible mentorship and cannot wait for the next chapter at @LurieCancer 🙏🏽

“Rather than telling the patient to come every day for five days for an IV chemotherapy treatment, we can just prescribe a pill they can take at home,” says our Dr. Nitin Jain. Learn about it here: brnw.ch/21wJVqo @NitinJainMD @TapKadia @HimaglobinA #leukemia #EndCancer

Looking forward to presenting investigator initiated phase 2 trial of time-limited pirtobrutinib + venetoclax + obinutuzumab as frontline Rx for pts with CLL at @EHA_Hematology EHA 2024 @wwierda @MDAndersonNews library.ehaweb.org/eha/2024/eha20…

@sanamloghavi also discussed #MRD in #AML: "Not all MRD is created equally," she said. "Not all the assays are as sensitive. So, you really have to know what you're using and how to interpret the data in the context of the greater picture."

Fantastic unanswered questions in #AML session by @Daver_Leukemia @sanamloghavi @Ramikomrokji @MikkaelSekeres Great discussion focused on importance and optimal sequencing of therapies for patients w AML - particularly those with targetable mutations! #HOPLive24

My takeaway front the #CML session with Dr. Jabbour, @MikkaelSekeres and @drsangeetmd : *our definitions of response (ELN, NCCN) need to be updated * be patient before you switch TKI, allow time for deep molecular response * and most importantly : thank you @mcuban #HOPLive24

🎙️ The Fellows Panel is underway at #HOPLive24! @heMEGirl_MD @AlexandraRojek @SedaToluMD @ZakerSchwabkey @HimaglobinA @HannahGoulart buff.ly/3xNw3wF

Happy to share our commentary in @practiceupdate shorturl.at/ipwMN with @HimaglobinA on this very timely and interesting paper on targeting molecular MRD by Ing Soo Tion, Andrew Wei and team in @JCO_ASCO shorturl.at/gCKLS  Thank you @Rfonsi1 for the opportunity #hemepath #molecular #leusm

@NitinJainMD No Sunday scaries with that face 😍

I hope you all had a great weekend! 🐶